<DOC>
	<DOC>NCT01434745</DOC>
	<brief_summary>The purpose of this study is to determine if simvastatin improves development and behavior in patients with Smith Lemli-Opitz syndrome (SLOS) receiving dietary cholesterol supplementation.</brief_summary>
	<brief_title>SLOS: The Effect of Simvastatin in Patients Receiving Cholesterol Supplementation</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Cleft Palate</mesh_term>
	<mesh_term>Hypertelorism</mesh_term>
	<mesh_term>Hypospadias</mesh_term>
	<mesh_term>Genetic Diseases, X-Linked</mesh_term>
	<mesh_term>Smith-Lemli-Opitz Syndrome</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>Male or female over 1 years old Subject has confirmed diagnosis of SmithLemliOpitz Syndrome Subject is currently receiving cholesterol supplementation Subjects too ill to travel to the study site Subjects who are unable to safely undergo study procedures Pregnant women</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>89 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>SLOS</keyword>
	<keyword>Cholesterol Supplementation</keyword>
	<keyword>Simvastatin</keyword>
</DOC>